Aug 05, 2015 at 17:39 | Source: PTI
As of now, the government keeps a tab on the prices of essential medicines which are included in the National List of Essential Medicines (NLEM). "There are about 100 crore people in the country who are either below poverty line, or in low income group or in middle income group.
Jul 27, 2015 at 14:58 | Source: Reuters
Sanofi's rare diseases division Genzyme will pay AstraZeneca up to USD 300 million for global rights to Caprelsa, including an upfront payment of USD 165 million and milestone payments based on the drug's performance of up to USD 135 million, the companies said on Monday.
Jul 25, 2015 at 16:02 | Source: CNBC
The injectable drugs, known as PCSK9 inhibitors, could cost an estimated USD 7,000 to USD 12,000 per year for each person using the drug.
Jul 23, 2015 at 14:04 | Source: Reuters
A group of 118 leading cancer experts have developed a list of proposals designed to reduce the cost of cancer drugs, and support a grassroots patient protest movement to pressure drug companies to charge what they deem a fair value for treatments.
Apr 08, 2015 at 14:39 | Source: PTI
The National Pharmaceutical Pricing Authority (NPPA) has issued a notification for price hike of drugs in line with the wholesale price index of 2014 under Drug Price Control Order, 2013.
Mar 27, 2015 at 09:44 | Source: PTI
Financial details of the transaction are not known. Zydus BSV Pharma develops, manufactures and markets non-infringing and proprietary novel drug delivery system (NDDS) of approved anti-cancer agents for global markets.
Mar 12, 2015 at 17:47 | Source: PTI
Apart from Europe, Ochoa Laboratories currently has operations in Uganda, Venezuala and Costa Rica among other Latin American and African countries. Dr Datsons Labs shares were trading 2.99 percent down at Rs 7.80 apiece during pre-close session on the BSE.
Feb 12, 2015 at 20:56 | Source: PTI
"Pursuant to the global deal, the company will have its distribution rights terminated for the oncology portfolio in return for accessing the distribution rights of the acquired vaccines portfolio," GlaxoSmithKline Pharmaceuticals Ltd said in a filing to the BSE.
Dec 23, 2014 at 20:21 | Source: PTI
The multi-layered deal involves UK-based GlaxoSmithKline (GSK) acquiring the Swiss major's vaccine business, while the latter would purchase GSK's cancer drugs portfolio.
Oct 31, 2014 at 11:01 | Source: PTI
An international organisation working for cancer affected people has asked the Obama administration not to pressurise India to reject a compulsory license on a drug for a rare form of leukaemia which would be a de facto endorsement of an excessive price.